Skip to main content
. 2021 Jul 20;8(3):370–377. doi: 10.5455/javar.2021.h525

Table 1. Hematological profile parameters in control and IVM-treated groups (mean ± SE).

Hematological parameters Control group (n = 10) IVM-treated group (n = 10)
RBCs (×106/mm3) 6.52 ± 0.18 7.24 ± 0.13*
Hb (g/dl) 7.56 ±.15 9.33 ± 0.3
PCV (%) 32.2 ± 0.9 40.2 ± 0.41*
TLC (×103/mm3) 11.05 ± 2 16.2 ± 1.1*
Lymphocytes (%) 48.62 ± 0.74 68.3 ± 0.63*
*

Significant difference between both groups when p < 0.05.